Efficacy and safety of bedaquiline in the treatment of multidrug/rifampicin resistant tuberculosis in Guangxi Zhuan
Bedaquiline is a much-needed novel drug which is highly effective against drug-resistant tuberculosi...
Bedaquiline and delamanid have been approved for treatment of multidrug-resistant (MDR) tuberculosis...
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) represents a major public health conce...
Objectives: To determine the safety and efficacy of bedaquiline for Chinese patients with multidrug-...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
The objective: to evaluate the efficiency of chemotherapy with bedaquiline in pulmonary tuberculosis...
Tuberculosis, caused by infection with Mycobacterium tuberculosis, is still a global concern. The ex...
The objective: to evaluate the efficiency of chemotherapy with bedaquiline in pulmonary tuberculosis...
The use of bedaquiline to treat patients with multidrug-resistant tuberculosis (MDR-TB) and end-stag...
In the conditions of the continued growth of multiple- and extensive drug-resistant tuberculosis, us...
Tuberculosis (TB) is a major health problem in developing countries. It is one of the leading cause ...
none3noNAopenTadolini, Marina*; Tiberi, Simon; Migliori, Giovanni BattistaTadolini, Marina*; Tiberi,...
Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant...
Bedaquiline is a much-needed novel drug which is highly effective against drug-resistant tuberculosi...
Bedaquiline and delamanid have been approved for treatment of multidrug-resistant (MDR) tuberculosis...
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) represents a major public health conce...
Objectives: To determine the safety and efficacy of bedaquiline for Chinese patients with multidrug-...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
The objective: to evaluate the efficiency of chemotherapy with bedaquiline in pulmonary tuberculosis...
Tuberculosis, caused by infection with Mycobacterium tuberculosis, is still a global concern. The ex...
The objective: to evaluate the efficiency of chemotherapy with bedaquiline in pulmonary tuberculosis...
The use of bedaquiline to treat patients with multidrug-resistant tuberculosis (MDR-TB) and end-stag...
In the conditions of the continued growth of multiple- and extensive drug-resistant tuberculosis, us...
Tuberculosis (TB) is a major health problem in developing countries. It is one of the leading cause ...
none3noNAopenTadolini, Marina*; Tiberi, Simon; Migliori, Giovanni BattistaTadolini, Marina*; Tiberi,...
Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant...
Bedaquiline is a much-needed novel drug which is highly effective against drug-resistant tuberculosi...
Bedaquiline and delamanid have been approved for treatment of multidrug-resistant (MDR) tuberculosis...
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) represents a major public health conce...
DOI
Add to ORKG